Dr. Vamsidhar Velcheti, MD
Claim this profileLaura and Isaac Perlmutter Cancer Center at NYU Langone
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
19 reported clinical trials
32 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
RET positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Vamsidhar Velcheti, MD is currently running
RET Inhibitor
for Solid Cancers
This trial is testing a new drug called TAS0953/HM06 for patients with advanced cancers that have specific genetic changes in the RET gene. The drug aims to block this gene to stop or slow down cancer growth. The initial part will find the safest dose, and the later part will test how well it works.
Recruiting1 award Phase 1 & 212 criteria
Nivolumab + Ramucirumab
for Non-Small Cell Lung Cancer
The study will enroll patients with prior IO therapy (alone or in combination with chemotherapy or in combination with other IO agents) regardless of the PD-L1 level, into a non-randomized combination trial, with primary endpoint of disease control rate.
Recruiting1 award Phase 215 criteria
More about Vamsidhar Velcheti, MD
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Vamsidhar Velcheti, MD has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- Nivolumab
- Docetaxel
- Placebo
Breakdown of trials Vamsidhar Velcheti, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vamsidhar Velcheti, MD specialize in?
Vamsidhar Velcheti, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vamsidhar Velcheti, MD currently recruiting for clinical trials?
Yes, Vamsidhar Velcheti, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Vamsidhar Velcheti, MD has studied deeply?
Yes, Vamsidhar Velcheti, MD has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Vamsidhar Velcheti, MD?
Apply for one of the trials that Vamsidhar Velcheti, MD is conducting.
What is the office address of Vamsidhar Velcheti, MD?
The office of Vamsidhar Velcheti, MD is located at: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York 10016 United States. This is the address for their practice at the Laura and Isaac Perlmutter Cancer Center at NYU Langone.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.